1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Global Antisense and RNAi Therapeutics Industry 2015 Market Research Report

Summary


The Global Antisense and RNAi Therapeutics Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Antisense and RNAi Therapeutics industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Antisense and RNAi Therapeutics market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Antisense and RNAi Therapeutics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 310 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Antisense and RNAi Therapeutics Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Antisense and RNAi Therapeutics
1.2 Classification of Antisense and RNAi Therapeutics
1.3 Applications of Antisense and RNAi Therapeutics
1.4 Industry Chain Structure of Antisense and RNAi Therapeutics
1.5 Industry Regional Overview of Antisense and RNAi Therapeutics
1.6 Industry Policy Analysis of Antisense and RNAi Therapeutics
1.7 Industry News Analysis of Antisense and RNAi Therapeutics

2 Manufacturing Cost Structure Analysis of Antisense and RNAi Therapeutics
2.1 Raw Material Suppliers and Price Analysis of Antisense and RNAi Therapeutics
2.2 Equipment Suppliers and Price Analysis of Antisense and RNAi Therapeutics
2.3 Labor Cost Analysis of Antisense and RNAi Therapeutics
2.4 Other Costs Analysis of Antisense and RNAi Therapeutics
2.5 Manufacturing Cost Structure Analysis of Antisense and RNAi Therapeutics
2.6 Manufacturing Process Analysis of Antisense and RNAi Therapeutics

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Global Key Antisense and RNAi Therapeutics Manufacturers in 2014
3.3 RandD Status and Technology Source of Global Antisense and RNAi Therapeutics Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Global Antisense and RNAi Therapeutics Key Manufacturers in 2014

4 Production Analysis of Antisense and RNAi Therapeutics by Regions, Technology, and Applications
4.1 Global Production of Antisense and RNAi Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015
4.2 Global Production of Antisense and RNAi Therapeutics by Technology 2010-2015
4.3 Global Production of Antisense and RNAi Therapeutics by Applications 2010-2015
4.4 Price Analysis of Global Antisense and RNAi Therapeutics Key Manufacturers in 2015
4.5 US Capacity, Production, Price, Cost and Revenue of Antisense and RNAi Therapeutics 2010-2015
4.6 EU Capacity, Production, Price, Cost and Revenue of Antisense and RNAi Therapeutics 2010-2015
4.7 Japan Capacity, Production, Price, Cost and Revenue of Antisense and RNAi Therapeutics 2010-2015
4.8 China Capacity, Production, Price, Cost and Revenue of Antisense and RNAi Therapeutics 2010-2015
4.9 US Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015
4.10 EU Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015
4.11 Japan Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015
4.12 China Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015

5 Sales and Revenue Analysis of Antisense and RNAi Therapeutics by Regions
5.1 Global Sales of Antisense and RNAi Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015
5.2 Global Revenue of Antisense and RNAi Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015
5.3 Global Price Analysis of Antisense and RNAi Therapeutics Sales by Regions (US, EU, China, Japan, etc.) 2010-2015
5.4 Global Price, Cost and Gross of Antisense and RNAi Therapeutics 2010-2015

6 Analysis of Antisense and RNAi Therapeutics Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity and Production of Antisense and RNAi Therapeutics 2010-2015
6.2 Production Market Share Analysis of Antisense and RNAi Therapeutics 2010-2015
6.3 Sales Overview of Antisense and RNAi Therapeutics 2010-2015
6.4 Supply, Sales and Shortage of Antisense and RNAi Therapeutics 2010-2015
6.5 Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Antisense and RNAi Therapeutics 2010-2015

7 Analysis of Antisense and RNAi Therapeutics Industry Key Manufacturers
7.1 Alnylam Pharmaceuticals
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity Production Price Cost Production Value
7.1.4 Contact Information

7.2 Isis Pharmaceuticals
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity Production Price Cost Production Value
7.2.4 Contact Information

7.3 Sanofi
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity Production Price Cost Production Value
7.3.4 Contact Information

7.4 Tekmira Pharmaceuticals
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity Production Price Cost Production Value
7.4.4 Contact Information

7.5 Acuitas Therapeutics
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity Production Price Cost Production Value
7.5.4 Contact Information

7.6 Allergan
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity Production Price Cost Production Value
7.6.4 Contact Information

7.7 Antisense Therapeutics
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity Production Price Cost Production Value
7.7.4 Contact Information

7.8 Ascletis
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity Production Price Cost Production Value
7.8.4 Contact Information

7.9 AstraZeneca
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity Production Price Cost Production Value
7.9.4 Contact Information

7.10 Atlantic Pharmaceuticals
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity Production Price Cost Production Value
7.10.4 Contact Information

7.11 Benitec Biopharma
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity Production Price Cost Production Value
7.11.4 Contact Information

7.12 Biogen Idec
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity Production Price Cost Production Value
7.12.4 Contact Information

7.13 Bristol-Myers Squibb
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity Production Price Cost Production Value
7.13.4 Contact Information

7.14 Dainippon Sumitomo Pharma
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity Production Price Cost Production Value
7.14.4 Contact Information

7.15 Dicerna Pharmaceuticals
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity Production Price Cost Production Value
7.15.4 Contact Information

7.16 Enzon Pharmaceuticals
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity Production Price Cost Production Value
7.16.4 Contact Information

7.17 F. Hoffmann-La Roche
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity Production Price Cost Production Value
7.17.4 Contact Information

7.18 Glaxosmithkline
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity Production Price Cost Production Value
7.18.4 Contact Information

7.19 Gradalis
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity Production Price Cost Production Value
7.19.4 Contact Information

7.20 iCo Therapeutics
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity Production Price Cost Production Value
7.20.4 Contact Information

7.21 Kyowa Hakko Kirin
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity Production Price Cost Production Value
7.21.4 Contact Information

7.22 Marina Biotech
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity Production Price Cost Production Value
7.22.4 Contact Information

7.23 Novartis
7.23.1 Company Profile
7.23.2 Product Picture and Specification
7.23.3 Capacity Production Price Cost Production Value
7.23.4 Contact Information

7.24 OncoGenex Pharmaceuticals
7.24.1 Company Profile
7.24.2 Product Picture and Specification
7.24.3 Capacity Production Price Cost Production Value
7.24.4 Contact Information

7.25 OPKO Health
7.25.1 Company Profile
7.25.2 Product Picture and Specification
7.25.3 Capacity Production Price Cost Production Value
7.25.4 Contact Information

7.26 Pfizer
7.26.1 Company Profile
7.26.2 Product Picture and Specification
7.26.3 Capacity Production Price Cost Production Value
7.26.4 Contact Information

7.27 Quark Pharmaceuticals
7.27.1 Company Profile
7.27.2 Product Picture and Specification
7.27.3 Capacity Production Price Cost Production Value
7.27.4 Contact Information

7.28 Regulus Therapeutics
7.28.1 Company Profile
7.28.2 Product Picture and Specification
7.28.3 Capacity Production Price Cost Production Value
7.28.4 Contact Information

7.29 Silence Therapeutics
7.29.1 Company Profile
7.29.2 Product Picture and Specification
7.29.3 Capacity Production Price Cost Production Value
7.29.4 Contact Information

7.30 Spectrum Pharmaceuticals
7.30.1 Company Profile
7.30.2 Product Picture and Specification
7.30.3 Capacity Production Price Cost Production Value
7.30.4 Contact Information

7.31 Sylentis
7.31.1 Company Profile
7.31.2 Product Picture and Specification
7.31.3 Capacity Production Price Cost Production Value
7.31.4 Contact Information

7.32 Takeda Pharmaceutical
7.32.1 Company Profile
7.32.2 Product Picture and Specification
7.32.3 Capacity Production Price Cost Production Value
7.32.4 Contact Information

7.33 Teva Pharmaceutical
7.33.1 Company Profile
7.33.2 Product Picture and Specification
7.33.3 Capacity Production Price Cost Production Value
7.33.4 Contact Information

7.34 The Medicines Company
7.34.1 Company Profile
7.34.2 Product Picture and Specification
7.34.3 Capacity Production Price Cost Production Value
7.34.4 Contact Information

7.35 TransDerm
7.35.1 Company Profile
7.35.2 Product Picture and Specification
7.35.3 Capacity Production Price Cost Production Value
7.35.4 Contact Information

8 Price and Gross Margin Analysis
8.1 Analysis of Price, Supply and Consumption
8.1.1 Price Analysis
8.1.2 Supply Analysis
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Antisense and RNAi Therapeutics Product Types
8.5 Market Share Analysis of Different Antisense and RNAi Therapeutics Price Levels
8.6 Gross Margin Analysis of Different Antisense and RNAi Therapeutics Applications

9 Marketing Trader or Distributor Analysis of Antisense and RNAi Therapeutics
9.1 Marketing Channels Status of Antisense and RNAi Therapeutics
9.2 Traders or Distributors of Antisense and RNAi Therapeutics with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Antisense and RNAi Therapeutics
9.4 Regional Import, Export and Trade Analysis of Antisense and RNAi Therapeutics

10 Development Trend of Antisense and RNAi Therapeutics Industry 2015-2020
10.1 Capacity and Production Overview of Antisense and RNAi Therapeutics 2015-2020
10.2 Production Market Share Analysis of Antisense and RNAi Therapeutics 2015-2020
10.3 Sales Overview of Antisense and RNAi Therapeutics 2015-2020
10.4 Supply, Sales, and Shortage of Antisense and RNAi Therapeutics 2015-2020
10.5 Import, Export and Consumption of Antisense and RNAi Therapeutics 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Antisense and RNAi Therapeutics 2015-2020

11 Industry Chain Suppliers of Antisense and RNAi Therapeutics with Contact Information
11.1 Major Raw Materials Suppliers of Antisense and RNAi Therapeutics with Contact Information
11.2 Manufacturing Equipment Suppliers of Antisense and RNAi Therapeutics with Contact Information
11.3 Major Suppliers of Antisense and RNAi Therapeutics with Contact Information
11.4 Key Consumers of Antisense and RNAi Therapeutics with Contact Information
11.5 Supply Chain Relationship Analysis of Antisense and RNAi Therapeutics

12 New Project Investment Feasibility Analysis of Antisense and RNAi Therapeutics
12.1 New Project SWOT Analysis of Antisense and RNAi Therapeutics
12.2 New Project Investment Feasibility Analysis of Antisense and RNAi Therapeutics

13 Conclusion of the Global Antisense and RNAi Therapeutics Industry 2015 Market Research Report


List of Tables and Figures
Figure Picture of Antisense and RNAi Therapeutics
Table Product Specifications of Antisense and RNAi Therapeutics
Figure Global Sales Market Share of Antisense and RNAi Therapeutics by Product Types in 2014
Figure Global Sales Market Share of Antisense and RNAi Therapeutics by Applications in 2014
Figure Industry Chain Structure of Antisense and RNAi Therapeutics
Table Global Major Antisense and RNAi Therapeutics Manufacturers
Table Industry Policy of Antisense and RNAi Therapeutics
Table Industry News List of Antisense and RNAi Therapeutics
Table Manufacturing Cost Structure Analysis of Antisense and RNAi Therapeutics in 2014
Figure Manufacturing Process Analysis of Antisense and RNAi Therapeutics
Table Capacity (K Person-portion) and Commercial Production Date of Global Antisense and RNAi Therapeutics Key Manufacturers in 2014
Table Manufacturing Plants Distribution of Global Key Antisense and RNAi Therapeutics Manufacturers in 2014
Table RandD Status and Technology Source of Global Antisense and RNAi Therapeutics Key Manufacturers in 2014
Table Raw Materials Sources Analysis of Global and China Antisense and RNAi Therapeutics Key Manufacturers in 2014
Table Global Production of Antisense and RNAi Therapeutics by Regions 2010-2015 (K Person-portion)
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Regions in 2010
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Regions in 2011
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Regions in 2012
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Regions in 2013
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Regions in 2014
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Regions in 2015
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Technology in 2010
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Technology in 2011
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Technology in 2012
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Technology in 2013
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Technology in 2014
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Technology in 2015
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Applications in 2010
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Applications in 2011
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Applications in 2012
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Applications in 2013
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Applications in 2014
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Applications in 2015
Figure Price Comparison of Global Antisense and RNAi Therapeutics Key Manufacturers in 2015 (USD/Person-portion)
Table US Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Antisense and RNAi Therapeutics 2010-2015
Table EU Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Antisense and RNAi Therapeutics 2010-2015
Table Japan Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Antisense and RNAi Therapeutics 2010-2015
Table China Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Antisense and RNAi Therapeutics 2010-2015
Table US Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015 (K Person-portion)
Table EU Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015 (K Person-portion)
Table Japan Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015 (K Person-portion)
Table China Supply, Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015 (K Person-portion)
Table Global Sales of Antisense and RNAi Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015 (K Person-portion)
Figure Global Sales of Antisense and RNAi Therapeutics by Regions (EU, China, Japan, etc.) in 2010 (K Person-portion)
Figure Global Sales of Antisense and RNAi Therapeutics by Regions (EU, China, Japan, etc.) in 2011 (K Person-portion)
Figure Global Sales of Antisense and RNAi Therapeutics by Regions (EU, China, Japan, etc.) in 2012 (K Person-portion)
Figure Global Sales of Antisense and RNAi Therapeutics by Regions (EU, China, Japan, etc.) in 2013 (K Person-portion)
Figure Global Sales of Antisense and RNAi Therapeutics by Regions (EU, China, Japan, etc.) in 2014 (K Person-portion)
Figure Global Sales of Antisense and RNAi Therapeutics by Regions (EU, China, Japan, etc.) in 2015 (K Person-portion)
Table Global Revenue of Antisense and RNAi Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015 (M USD)
Figure Global Revenue of Antisense and RNAi Therapeutics by Regions (US, EU, China, Japan, etc.) in 2010 (M USD)
Figure Global Revenue of Antisense and RNAi Therapeutics by Regions (US, EU, China, Japan, etc.) in 2011 (M USD)
Figure Global Revenue of Antisense and RNAi Therapeutics by Regions (US, EU, China, Japan, etc.) in 2012 (M USD)
Figure Global Revenue of Antisense and RNAi Therapeutics by Regions (US, EU, China, Japan, etc.) in 2013 (M USD)
Figure Global Revenue of Antisense and RNAi Therapeutics by Regions (US, EU, China, Japan, etc.) in 2014 (M USD)
Figure Global Revenue of Antisense and RNAi Therapeutics by Regions (US, EU, China, Japan, etc.) in 2015 (M USD)
Table Sale Price of Antisense and RNAi Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015 (USD/Person-portion)
Figure Global Price Analysis of Antisense and RNAi Therapeutics 2010-2015 (USD/Person-portion)
Figure Global Cost Analysis of Antisense and RNAi Therapeutics 2010-2015 (USD/Person-portion)
Figure Global Gross Analysis of Antisense and RNAi Therapeutics 2010-2015
Table Global and Major Manufacturers Capacity of Antisense and RNAi Therapeutics 2010-2015 (K Person-portion)
Table Global Capacity Market Share of Major Antisense and RNAi Therapeutics Manufacturers 2010-2015
Table Global and Major Manufacturers Production of Antisense and RNAi Therapeutics 2010-2015 (K Person-portion)
Table Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers 2010-2015
Figure Global Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Antisense and RNAi Therapeutics 2010-2015
Figure Global Capacity Utilization Rate of Antisense and RNAi Therapeutics 2010-2015
Table Global and Major Manufacturers Revenue of Antisense and RNAi Therapeutics 2010-2015 (M USD)
Table Global Revenue Market Share of Major Antisense and RNAi Therapeutics Manufacturers 2010-2015
Figure Global Revenue (M USD) and Growth Rate of Antisense and RNAi Therapeutics 2010-2015
Table China and Major Manufacturers Capacity of Antisense and RNAi Therapeutics 2010-2015 (K Person-portion)
Table Capacity Market Share of China Major Antisense and RNAi Therapeutics Manufacturers 2010-2015
Table China and Major Manufacturers Production 2010-2015 (K Person-portion)
Table Production Market Share of China Major Manufacturers 2010-2015
Figure China Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Antisense and RNAi Therapeutics 2010-2015
Figure China Capacity Utilization Rate of Antisense and RNAi Therapeutics 2010-2015
Table China and Major Manufacturers Revenue of Antisense and RNAi Therapeutics 2010-2015 (M USD)
Table Revenue Market Share of China Major Manufacturers 2010-2015
Figure China Revenue (M USD) and Growth Rate of Antisense and RNAi Therapeutics 2010-2015
Figure Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2010
Figure Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2011
Figure Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2012
Figure Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2013
Figure Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2014
Figure Global Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2015
Figure China Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2010
Figure China Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2011
Figure China Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2012
Figure China Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2013
Figure China Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2014
Figure China Production Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2015
Figure Global Sales (K Person-portion) and Growth Rate of Antisense and RNAi Therapeutics 2010-2015
Figure China Sales (K Person-portion) and Growth Rate of Antisense and RNAi Therapeutics 2010-2015
Table Global Supply, Sales and Shortage of Antisense and RNAi Therapeutics 2010-2015 (K Person-portion)
Table China Supply, Sales and Shortage of Antisense and RNAi Therapeutics 2010-2015 (K Person-portion)
Table China Import, Export and Consumption of Antisense and RNAi Therapeutics 2010-2015 (K Person-portion)
Table Price of Global Antisense and RNAi Therapeutics Major Manufacturers 2010-2015 (USD/Person-portion)
Figure Price Comparison by Global Major Antisense and RNAi Therapeutics Manufacturers in 2014 (USD/Person-portion)
Table Gross Margin of Global Antisense and RNAi Therapeutics Major Manufacturers 2010-2015
Figure Gross Margin of Global Antisense and RNAi Therapeutics Major Manufacturers in 2014
Table Global and Major Manufacturers Revenue of Antisense and RNAi Therapeutics 2010-2015 (M USD)
Table Global Revenue Market Share of Major Antisense and RNAi Therapeutics Manufacturers 2010-2015
Figure Global Revenue Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2011
Figure Global Revenue Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2012
Figure Global Revenue Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2013
Figure Global Revenue Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2014
Figure Global Revenue Market Share of Major Antisense and RNAi Therapeutics Manufacturers in 2015
Table China and Major Manufacturers of Antisense and RNAi Therapeutics 2010-2015 (M USD)
Table Revenue Market Share of China Antisense and RNAi Therapeutics Major Manufacturers 2010-2015
Table Global Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Antisense and RNAi Therapeutics 2010-2015
Table China Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Antisense and RNAi Therapeutics 2010-2015
Figure Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Product Picture
Table Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Product Specification
Table 2010-2015 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Product Production Global Market Share
Figure Isis Pharmaceuticals Antisense and RNAi Therapeutics Product Picture
Table Isis Pharmaceuticals Antisense and RNAi Therapeutics Product Specification
Table 2010-2015 Isis Pharmaceuticals Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Isis Pharmaceuticals Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Isis Pharmaceuticals Antisense and RNAi Therapeutics Product Production Global Market Share
Figure Sanofi Antisense and RNAi Therapeutics Product Picture
Table Sanofi Antisense and RNAi Therapeutics Product Specification
Table 2010-2015 Sanofi Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Sanofi Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Sanofi Antisense and RNAi Therapeutics Product Production Global Market Share
Figure Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Product Picture
Table Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Product Specification
Table 2010-2015 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Product Production Global Market Share
Figure Acuitas Therapeutics Antisense and RNAi Therapeutics Product Picture
Table Acuitas Therapeutics Antisense and RNAi Therapeutics Product Specification
Table 2010-2015 Acuitas Therapeutics Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Acuitas Therapeutics Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Acuitas Therapeutics Antisense and RNAi Therapeutics Product Production Global Market Share
Figure Allergan Antisense and RNAi Therapeutics Product Picture
Table Allergan Antisense and RNAi Therapeutics Product Specification
Table 2010-2015 Allergan Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Allergan Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Allergan Antisense and RNAi Therapeutics Product Production Global Market Share
Figure Antisense Therapeutics Antisense and RNAi Therapeutics Product Picture
Table Antisense Therapeutics Antisense and RNAi Therapeutics Product Specification
Table 2010-2015 Antisense Therapeutics Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Antisense Therapeutics Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Antisense Therapeutics Antisense and RNAi Therapeutics Product Production Global Market Share
Figure Ascletis Antisense and RNAi Therapeutics Product Picture
Table Ascletis Antisense and RNAi Therapeutics Product Specification
Table 2010-2015 Ascletis Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Ascletis Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Ascletis Antisense and RNAi Therapeutics Product Production Global Market Share
Figure AstraZeneca Antisense and RNAi Therapeutics Product Picture
Table AstraZeneca Antisense and RNAi Therapeutics Product Specification
Table 2010-2015 AstraZeneca Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 AstraZeneca Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 AstraZeneca Antisense and RNAi Therapeutics Product Production Global Market Share
Figure Atlantic Pharmaceuticals Antisense and RNAi Therapeutics Product Picture
Table Atlantic Pharmaceuticals Antisense and RNAi Therapeutics Product Specification
Table 2010-2015 Atlantic Pharmaceuticals Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Atlantic Pharmaceuticals Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Atlantic Pharmaceuticals Antisense and RNAi Therapeutics Product Production Global Market Share
Figure Benitec Biopharma Antisense and RNAi Therapeutics Product Picture
Table Benitec Biopharma Antisense and RNAi Therapeutics Product Specification
Table 2010-2015 Benitec Biopharma Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Benitec Biopharma Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Benitec Biopharma Antisense and RNAi Therapeutics Product Production Global Market Share
Figure Biogen Idec Antisense and RNAi Therapeutics Product Picture
Table Biogen Idec Antisense and RNAi Therapeutics Product Specification
Table 2010-2015 Biogen Idec Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Biogen Idec Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Biogen Idec Antisense and RNAi Therapeutics Product Production Global Market Share
Figure Bristol-Myers Squibb Antisense and RNAi Therapeutics Product Picture
Table Bristol-Myers Squibb Antisense and RNAi Therapeutics Product Specification
Table 2010-2015 Bristol-Myers Squibb Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Bristol-Myers Squibb Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Bristol-Myers Squibb Antisense and RNAi Therapeutics Product Production Global Market Share
Figure Dainippon Sumitomo Pharma Antisense and RNAi Therapeutics Product Picture
Table Dainippon Sumitomo Pharma Antisense and RNAi Therapeutics Product Specification
Table 2010-2015 Dainippon Sumitomo Pharma Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Dainippon Sumitomo Pharma Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Dainippon Sumitomo Pharma Antisense and RNAi Therapeutics Product Production Global Market Share
Figure Dicerna Pharmaceuticals Antisense and RNAi Therapeutics Product Picture
Table Dicerna Pharmaceuticals Antisense and RNAi Therapeutics Product Specification
Table 2010-2015 Dicerna Pharmaceuticals Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Dicerna Pharmaceuticals Antisense and RNAi Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Dicerna Pharmaceuticals Antisense and RNAi Therapeutics Product Production Global Market Share
Figure Enzon Pharmaceuticals Antisense and RNAi Therapeutics Product Picture
Table Enzon Pharmaceuticals Antis

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
RNAi Technologies and Global Markets

RNAi Technologies and Global Markets

  • $ 6650
  • Industry report
  • January 2016
  • by BCC Research

This BCC Research report summarizes the global RNAi technologies market by category and by region. The RNAi market is analyzed based on RNAi research tools and reagents as well as on RNAi diagnostics. ...

Flat-Rate Access to R&D Database & Reports from La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing

  • $ 8470
  • Industry report
  • November 2016
  • by La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing - R&D Drug Pipeline Database: 1-Year Subscription - Flat-Rate Subscription to La Merie Publishing Reports & News Services A one-yea ...

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • August 2016
  • by GBI Research

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.